General Information of the Compound
| Compound ID |
CP0403752
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-(1-benzylpiperidin-4-yl)-5-chloro-1H-indole
Show/Hide
|
||||||||||||||||||
| Synonyms |
3-(1-benzylpiperidin-4-yl)-5-chloro-1H-indole
BDBM50185792
CHEMBL210770
NRIVFQIOYWIUPX-UHFFFAOYSA-N
SCHEMBL14280723
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H21ClN2
|
||||||||||||||||||
| Molecular Weight |
324.855
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc2[nH]cc(C3CCN(Cc4ccccc4)CC3)c2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H21ClN2/c21-17-6-7-20-18(12-17)19(13-22-20)16-8-10-23(11-9-16)14-15-4-2-1-3-5-15/h1-7,12-13,16,22H,8-11,14H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
NRIVFQIOYWIUPX-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor
Protein ID: PT01360, Nociceptin receptor
Clinical Information about the Compound